Literature DB >> 7639329

Collagen remodeling after myocardial infarction in the rat heart.

J P Cleutjens1, M J Verluyten, J F Smiths, M J Daemen.   

Abstract

In this study changes in the amount and distribution of types I and III collagen mRNA and protein were investigated in the rat heart after induction of a left ventricular myocardial infarction (MI). Sham operated rats served as controls. The animals were sacrificed at different time intervals after operation. Northern blotting of cardiac RNA and hybridization with cDNA probes for types I and III procollagen revealed a 5- to 15-fold increase in the infarcted left ventricle. Type III procollagen mRNA levels were already increased at day 2 after MI, whereas type I procollagen mRNA followed this response at day 4 after MI. This increase was sustained for at least 21 days in the infarcted left ventricle for type III procollagen mRNA, whereas type 1 procollagen mRNA levels were still elevated at 90 days after MI. In the noninfarcted right ventricle a 5- to 7-fold increase was observed for both type I and type III procollagen mRNA levels, but only at day 4 after MI. In the non-infarcted septum a transient increase was observed for type I procollagen mRNA from day 7-21 (4- to 5-fold increase) and a decline to sham levels thereafter. In the septum type III procollagen mRNA levels were only elevated at 7 days after MI (4- to 5-fold increase) compared with sham operated controls. In situ hybridization with the same types I and III procollagen probes showed procollagen mRNA-producing cells in the infarcted area around necrotic cardiomyocytes, and in the interstitial cells in the non-infarcted part of the myocardium. No labeling was detected above cardiomyocytes. Combined in situ hybridization and immunohistochemistry showed that the collagen mRNA producing cells have a myofibroblast-like phenotype in the infarcted myocardium and are fibroblasts in the noninfarcted septum and right ventricle. The increase in types I and III procollagen mRNA in both infarcted and non-infarcted myocardium was followed by an increased collagen deposition, measured by computerized morphometry on sirius red-stained tissue sections as well as by the hydroxyproline assay. In the non-infarcted septum and right ventricle the collagen-positive area was maximal at day 14 (3- to 5-fold increase compared with sham operated controls) and slightly declined at day 21. In the infarcted myocardium the collagen-positive area was 57 +/- 10% at day 14 after MI. Hydroxyproline contents were significantly increased in the noninfarcted septum.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639329      PMCID: PMC1869816     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  55 in total

1.  Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs.

Authors:  M Metsäranta; D Toman; B De Crombrugghe; E Vuorio
Journal:  Biochim Biophys Acta       Date:  1991-06-13

Review 2.  The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence.

Authors:  K Lindpaintner; D Ganten
Journal:  Circ Res       Date:  1991-04       Impact factor: 17.367

Review 3.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling.

Authors:  J F Woessner
Journal:  FASEB J       Date:  1991-05       Impact factor: 5.191

4.  Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections.

Authors:  L C Junqueira; G Bignolas; R R Brentani
Journal:  Histochem J       Date:  1979-07

5.  Enhanced deposition of predominantly type I collagen in myocardial disease.

Authors:  J E Bishop; R Greenbaum; D G Gibson; M Yacoub; G J Laurent
Journal:  J Mol Cell Cardiol       Date:  1990-10       Impact factor: 5.000

6.  Quantitative assessment of the age of fibrotic lesions using polarized light microscopy and digital image analysis.

Authors:  J G Pickering; D R Boughner
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

7.  Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors.

Authors:  M Eghbali; R Tomek; V P Sukhatme; C Woods; B Bhambi
Journal:  Circ Res       Date:  1991-08       Impact factor: 17.367

8.  Specific alterations in the distribution of extracellular matrix components within rat myocardium during the development of pressure overload.

Authors:  F Contard; V Koteliansky; F Marotte; I Dubus; L Rappaport; J L Samuel
Journal:  Lab Invest       Date:  1991-01       Impact factor: 5.662

Review 9.  Cardiac remodeling in hypertension and following myocardial infarction: effects of arteriolar vasodilators.

Authors:  J F Smits; J P Cleutjens; C van Krimpen; R G Schoemaker; M J Daemen
Journal:  Basic Res Cardiol       Date:  1991       Impact factor: 17.165

10.  Angiotensin I converting enzyme inhibitors and cardiac remodeling.

Authors:  C van Krimpen; R G Schoemaker; J P Cleutjens; J F Smits; H A Struyker-Boudier; F T Bosman; M J Daemen
Journal:  Basic Res Cardiol       Date:  1991       Impact factor: 17.165

View more
  152 in total

Review 1.  The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling.

Authors:  Joseph S Janicki; Gregory L Brower; Jason D Gardner; Amanda L Chancey; James A Stewart
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

Review 2.  Extra-cellular matrix in vascular networks.

Authors:  George Bou-Gharios; Markella Ponticos; Vineeth Rajkumar; David Abraham
Journal:  Cell Prolif       Date:  2004-06       Impact factor: 6.831

3.  Molecular imaging of interstitial alterations after myocardial infarction.

Authors:  Johan Verjans; Leonard Hofstra; Jagat Narula
Journal:  J Cardiovasc Transl Res       Date:  2008-06-28       Impact factor: 4.132

4.  Time course of early changes in plasma markers of collagen turnover following percutaneous transluminal coronary angioplasty.

Authors:  Andrew Douglas McGavigan; Paul R Maxwell; Francis G Dunn
Journal:  Can J Cardiol       Date:  2010-11       Impact factor: 5.223

5.  Exogenously administered secreted frizzled related protein 2 (Sfrp2) reduces fibrosis and improves cardiac function in a rat model of myocardial infarction.

Authors:  Wei He; Lunan Zhang; Aiguo Ni; Zhiping Zhang; Maria Mirotsou; Lan Mao; Richard E Pratt; Victor J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

Review 6.  Diagnostic and therapeutic potential of the endothelin system in patients with chronic heart failure.

Authors:  H Krum; R Denver; A Tzanidis; P Martin
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 7.  Fibroblasts in myocardial infarction: a role in inflammation and repair.

Authors:  Arti V Shinde; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2013-12-07       Impact factor: 5.000

Review 8.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

Review 9.  Cardiac fibroblasts : Active players in (atrial) electrophysiology?

Authors:  Alexander Klesen; Dorothee Jakob; Ramona Emig; Peter Kohl; Ursula Ravens; Rémi Peyronnet
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-02-01

10.  Cell biological mechanisms in regulation of the post-infarction inflammatory response.

Authors:  Nikolaos G Frangogiannis
Journal:  Curr Opin Physiol       Date:  2017-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.